NIKKEI 225
29,137.46 +537.05 (+1.88%) HANG SENG
26,011.67 -120.36 (-0.46%) CRUDE OIL
83.72 -0.04 (-0.05%) GOLD FUTURES
1,805.80 -1.00 (-0.06%) DOW
35,741.15 +64.13 (+0.18%) BTC-GBP
45,368.56 +194.67 (+0.43%)
Hengan International Group Company Limited (1044.HK)
| Previous close | 41.200 |
| Open | 41.200 |
| Bid | 40.650 x 0 |
| Ask | 40.700 x 0 |
| Day's range | 40.500 - 41.350 |
| 52-week range | 40.100 - 59.300 |
| Volume | 1,730,441 |
| Avg. volume | 2,739,114 |
| Market cap | 47.24B |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 11.07 |
| EPS (TTM) | 3.671 |
| Earnings date | 18 Aug 2021 |
| Forward dividend & yield | 2.76 (6.69%) |
| Ex-dividend date | 10 Sept 2021 |
| 1y target est | 50.74 |
- Business Wire
Perimeter Medical Imaging AI Announces U.S. FDA 510(k) Clearance for OCT Imaging System
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Perimeter’s Optical Coherence Tomography (OCT) Imaging System (v2.1), which is designed to examine tissue microstructures during surgical procedures by providing cross-sectional, real-time margin visualization.
- Business Wire
Perimeter Medical Imaging AI Provides Update on Exercise of Warrants
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) ("Perimeter" or the "Company"), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, today provided an update on its previously announced acceleration of the expiry date of the share purchase warrants issued by the Company on June 29, 2020 (the "Warrants").
